Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / atorvastatin attending: chief complaint: chest tightness/doe major surgical or invasive procedure: cabg x 2, mvrepair, asd closure history of present illness: 59 yo m with known cad, previous stent, with increasing angina and positive ett. past medical history: mi pci to lad and lcx htn lipids obesity mva s/p bilat knee arthroscopy s/p deviated septum repair social history: denies tobacco, etoh, drug use family history: mother with dm. denies cad. physical exam: admission exam unremarkable with the exception of 1+ ble edema. pertinent results: 06:45am blood wbc-7.3 rbc-2.85* hgb-8.8* hct-26.5* mcv-93 mch-31.0 mchc-33.3 rdw-13.1 plt ct-166 06:45am blood plt ct-166 06:05am blood pt-11.9 ptt-30.1 inr(pt)-1.0 06:45am blood glucose-113* urean-17 creat-0.9 na-135 k-4.0 cl-98 hco3-30 angap-11 04:12am blood wbc-9.3 rbc-3.05* hgb-9.5* hct-28.0* mcv-92 mch-31.1 mchc-34.0 rdw-13.5 plt ct-253 04:12am blood plt ct-253 04:12am blood pt-11.9 ptt-28.3 inr(pt)-1.0 04:12am blood glucose-102 urean-15 creat-1.0 na-134 k-3.9 cl-94* hco3-32 angap-12 04:12am blood calcium-8.2* phos-4.3# mg-2.6 echocardiography report , (complete) done at 8:40:47 am final referring physician information , division of cardiothoracic , status: inpatient dob: age (years): 59 m hgt (in): 70 bp (mm hg): / wgt (lb): 330 hr (bpm): bsa (m2): 2.58 m2 indication: left ventricular function. mitral valve disease. intra-op tee for cabg, mvr, pfo closure icd-9 codes: 745.5, 413.9, 414.8, 424.0 test information date/time: at 08:40 interpret md: , md test type: tee (complete) son: , md doppler: full doppler and color doppler test location: anesthesia west or cardiac contrast: none tech quality: adequate tape #: 2007aw06-: machine: echocardiographic measurements results measurements normal range left ventricle - ejection fraction: 30% to 35% >= 55% findings right atrium/interatrial septum: dynamic interatrial septum. left-to-right shunt across the interatrial septum at rest. small secundum asd. left ventricle: normal lv wall thickness. moderately dilated lv cavity. moderately depressed lvef. lv wall motion: regional left ventricular wall motion findings as shown below; remaining lv segments contract normally. right ventricle: mildly dilated rv cavity. mild global rv free wall hypokinesis. aorta: normal aortic diameter at the sinus level. focal calcifications in aortic root. mildly dilated ascending aorta. focal calcifications in ascending aorta. normal aortic arch diameter. focal calcifications in aortic arch. mildly dilated descending aorta. simple atheroma in descending aorta. aortic valve: three aortic valve leaflets. no as. no ar. mitral valve: mildly thickened mitral valve leaflets. mild mitral annular calcification. no ms. moderate (2+) mr. tricuspid valve: moderate tr. pulmonic valve/pulmonary artery: physiologic (normal) pr. general comments: a tee was performed in the location listed above. i certify i was present in compliance with hcfa regulations. no tee related complications. the patient was under general anesthesia throughout the procedure. the patient appears to be in sinus rhythm. results were personally reviewed with the md caring for the patient. see conclusions for post-bypass data regional left ventricular wall motion: n = normal, h = hypokinetic, a = akinetic, d = dyskinetic conclusions pre-bypass: a left-to-right shunt across the interatrial septum is seen at rest. a small secundum atrial septal defect is present. left ventricular wall thicknesses are normal. the left ventricular cavity is moderately dilated. overall left ventricular systolic function is moderately depressed. the right ventricular cavity is mildly dilated. there is mild global right ventricular free wall hypokinesis. the ascending aorta is mildly dilated. there are focal calcifications in the aortic arch. the descending thoracic aorta is mildly dilated. there are simple atheroma in the descending thoracic aorta. there are three aortic valve leaflets. there is no aortic valve stenosis. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. moderate (2+) mitral regurgitation is seen. moderate tricuspid regurgitation is seen. on manipulation of the blood pressure, the mr was 3+ at a systolic pressure of 150 mmhg. there is a central jet with bileaflet retraction and a globular shape of the lv cavity. on bypass: the asd by inspection shows multiple perforations of the septum. on review of the clips, there are two distinct areas of transseptal left-to-right flow in the membranous portion. post-bypass: epi, phenylephrine, amiodarone infusion. there is a well-seated annular ring of the mitral valve with no mitral regurgitation seen. biventricular systolic function is slightly improved on inotropic support with lvef 35%. areas of wall motion abnormalities are unchanged post-cpb.there is no asd seen by color doppler and by bubble study. aortic contours are normal post-decannulation. i certify that i was present for this procedure in compliance with hcfa regulations. electronically signed by , md, interpreting physician ?????? caregroup is. all rights reserved. brief hospital course: he was taken to the operating room on where he underwent a cabg x 2, mvrepair, and asd closure. he was transferred to the sicu in critical but stable condition. he was extubated and weaned from his vasoactive drips that evening. he was transferred to the floor on pod #1. he continued to do well postoperatively. he was diuresed toward his preop weight and began to increase his activity level. chest tubes and pacing wires were removed without incident. cleared for discharge to home with services on pod # 6. pt. is to make all follow-up appts. as per discharge instructions. medications on admission: lisinopril toprol plavix zetia pravachol darvocet percocet discharge medications: 1. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 3. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 4. pravastatin 20 mg tablet sig: four (4) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 5. ascorbic acid 500 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 6. ferrous sulfate 325 (65) mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 7. oxycodone 10 mg tablet sustained release 12hr sig: one (1) tablet sustained release 12hr po q12h (every 12 hours). disp:*40 tablet sustained release 12hr(s)* refills:*2* 8. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q6h (every 6 hours) as needed. disp:*45 tablet(s)* refills:*0* 9. ibuprofen 400 mg tablet sig: 1-2 tablets po every 6-8 hours as needed. disp:*60 tablet(s)* refills:*0* 10. metoprolol tartrate 50 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 11. furosemide 40 mg tablet sig: 1.5 tablets po q12h (every 12 hours) for 7 days: 60mg for 7 days then 40mg for 7 days then stop. disp:*35 tablet(s)* refills:*0* 12. potassium chloride 10 meq capsule, sustained release sig: four (4) capsule, sustained release po q12h (every 12 hours) for 14 days. disp:*112 capsule, sustained release(s)* refills:*0* discharge disposition: home with service facility: hospice and vna discharge diagnosis: cad, mr mi pci to lad and lcx htn lipids obesity mva s/p bilat knee arthroscopy s/p deviated septum repair discharge condition: good. discharge instructions: call with fever, redness or drainage from incision or weight gain more than 2 pounds in one day or five in one week. shower, no baths, no lotions creams or powders to incisions. no heavy llifting (more than 10 pounds) or driving until follow up with surgeon. followup instructions: , follow-up appointment should be in 2 weeks , follow-up appointment should be in 1 month , d. follow-up appointment should be in 2 weeks procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of one coronary artery other and unspecified repair of atrial septal defect open heart valvuloplasty of mitral valve without replacement diagnoses: coronary atherosclerosis of native coronary artery mitral valve disorders unspecified essential hypertension other and unspecified angina pectoris acquired cardiac septal defect 

Answer: The patient is high likely exposed to